Clinical Trial TitleRetrospective chart review of patients with fibrolamellar carcinoma.
Clinical Trial Protocol Description:
This is a retrospective chart review of patients with fibrolamellar carcinoma allowing investigators to review data on their treatment, labs, imaging, surgeries and outcomes in a de-identified, anonymous way to allow for better understanding of fibrolamellar carcinoma.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have confirmed fibrolamellar carcinoma and has had some or all of treatment at Rush.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.